Bridgebio Pharma Inc (BBIO)

Cost of Revenue

$15.05M

Quarterly · Period ending: · USD

BBIO logo

BBIO Cost of Revenue

Latest reported$15.05M
BBIO Quarterly Cost of Revenue ($0.00 → $15.05M)
High-resolution chart · PNG

BBIO cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
15,046,000
10,425,000
15,418,000
6,563,000
3,653,000
2,639,000
2,084,000
598,000
598,000
598,000
598,000
598,000
599,000
651,000
647,000
739,000
700,000
1,348,000
1,551,000
1,454,000
109,000
0
0
0
0
0
0
2,500,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.